Cargando…

Stronger implicit interference in cognitively healthy older participants with higher risk of Alzheimer's disease

INTRODUCTION: Abnormal cerebrospinal fluid amyloid beta (Aβ)(42) and tau levels have been revealed decades before symptoms onset in Alzheimer's disease (AD); however, the examination is usually invasive and inaccessible to most people. We thus aimed to develop a non‐invasive behavioral test tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hung, Shao‐Min, Wu, Daw‐An, Shimojo, Shinsuke, Arakaki, Xianghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Diagnostic and Prognostic Assessment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489163/ https://www.ncbi.nlm.nih.gov/pubmed/36187196 http://dx.doi.org/10.1002/dad2.12340

Ejemplares similares

Practice makes imperfect: stronger implicit interference with practice in individuals at high risk of developing Alzheimer’s disease
por: Hung, Shao-Min, et al.
Publicado: (2023)

Sex‐specific biomarkers in Alzheimer's disease progression: Framingham Heart Study
por: Liu, Chunyu, et al.
Publicado: (2022)

Life satisfaction across the entire trajectory of Alzheimer's disease: A mediation analysis
por: Mank, Arenda, et al.
Publicado: (2022)

Memory‐driven eye movements prospectively predict dementia in people at risk of Alzheimer's disease
por: Parra, Mario A, et al.
Publicado: (2022)

Mayo normative studies: A conditional normative model for longitudinal change on the Auditory Verbal Learning Test and preliminary validation in preclinical Alzheimer's disease
por: Alden, Eva C., et al.
Publicado: (2022)

Comorbidity patterns in institutionalized older adults affected by dementia
por: Zazzara, Maria Beatrice, et al.
Publicado: (2022)

Exploring discordant low amyloid beta and high neocortical tau positron emission tomography cases
por: Krishnadas, Natasha, et al.
Publicado: (2022)

A proposed theoretical framework for retinal biomarkers
por: MacCormick, Ian James Callum, et al.
Publicado: (2022)

Weight loss in a cardiovascular trial population identifies people at future risk of dementia
por: van der Veere, Pieter, et al.
Publicado: (2022)

Development and design of a diagnostic report to support communication in dementia: Co‐creation with patients and care partners
por: van Gils, Aniek M., et al.
Publicado: (2022)

Is there a common latent cognitive construct for dementia estimation across two Chinese cohorts?
por: Liu, Yuyang, et al.
Publicado: (2022)

Medicare's Annual Wellness Visit and diagnoses of dementias and cognitive impairment
por: Thunell, Johanna A., et al.
Publicado: (2022)

Development and implementation of an electronic Clinical Dementia Rating and Financial Capacity Instrument‐Short Form
por: Howell, Taylor, et al.
Publicado: (2022)

No difference in retinal fluorescence after oral curcumin intake in amyloid‐proven AD cases compared to controls
por: den Haan, Jurre, et al.
Publicado: (2022)

Optimizing cCOG, a Web‐based tool, to detect dementia with Lewy Bodies
por: van Gils, Aniek M., et al.
Publicado: (2022)

Evaluation of blood‐based, extracellular vesicles as biomarkers for aging‐related TDP‐43 pathology
por: Winston, Charisse N., et al.
Publicado: (2022)

Women's higher brain metabolic rate compensates for early Alzheimer's pathology
por: Sundermann, Erin E., et al.
Publicado: (2020)

The DecisionDx-UM Gene Expression Profile Test Provides Risk Stratification and Individualized Patient Care in Uveal Melanoma
por: Harbour, J. William, et al.
Publicado: (2013)

Task-induced attention load guides and gates unconscious semantic interference
por: Hung, Shao-Min, et al.
Publicado: (2020)

Meeting physical activity recommendations may be protective against temporal lobe atrophy in older adults at risk for Alzheimer's disease
por: Dougherty, Ryan J., et al.
Publicado: (2016)

Alzheimer's disease severity, objectively determined and measured
por: Gross, Alden L., et al.
Publicado: (2016)

Prognostic value of ATN Alzheimer biomarkers: 60‐month follow‐up results from the Argentine Alzheimer's Disease Neuroimaging Initiative
por: Allegri, Ricardo F., et al.
Publicado: (2020)

Function and clinical meaningfulness of treatments for mild Alzheimer's disease
por: Siemers, Eric, et al.
Publicado: (2016)

Revolutionizing Alzheimer's disease and clinical trials through biomarkers
por: Mattsson, Niklas, et al.
Publicado: (2015)

Detection of presymptomatic Alzheimer's disease through breath biomarkers
por: Emam, Shadi, et al.
Publicado: (2020)

Is diabetes associated with increased pathological burden in Alzheimer's disease?
por: Sadrolashrafi, Kaviyon, et al.
Publicado: (2021)

Periodontal disease's contribution to Alzheimer's disease progression in Down syndrome
por: Kamer, Angela R., et al.
Publicado: (2016)

Challenges associated with biomarker-based classification systems for Alzheimer's disease
por: Illán-Gala, Ignacio, et al.
Publicado: (2018)

Development and validation of a salivary tau biomarker in Alzheimer's disease
por: Pekeles, Heather, et al.
Publicado: (2018)

Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design
por: de Wilde, Arno, et al.
Publicado: (2017)

Assessing quality of life in Alzheimer's disease: Implications for clinical trials
por: Kahle-Wrobleski, Kristin, et al.
Publicado: (2016)

Multimodal prediction of conversion to Alzheimer's disease based on incomplete biomarkers
por: Ritter, Kerstin, et al.
Publicado: (2015)

The Consortium for the early identification of Alzheimer's disease–Quebec (CIMA-Q)
por: Belleville, Sylvie, et al.
Publicado: (2019)

The Health & Aging Brain among Latino Elders (HABLE) study methods and participant characteristics
por: O'Bryant, Sid E., et al.
Publicado: (2021)

Theoretical frameworks and approaches used within the Reserve, Resilience and Protective Factors professional interest area of the Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment
por: Bartrés‐Faz, David, et al.
Publicado: (2020)

Random forest to differentiate dementia with Lewy bodies from Alzheimer's disease
por: Dauwan, Meenakshi, et al.
Publicado: (2016)

The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions
por: Johnson, Sterling C., et al.
Publicado: (2017)

Relationship between frailty and Alzheimer's disease biomarkers: A scoping review
por: Wallace, Lindsay, et al.
Publicado: (2018)

Copper and zinc isotopic excursions in the human brain affected by Alzheimer's disease
por: Moynier, Frédéric, et al.
Publicado: (2020)

Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans
por: Jutkowitz, Eric, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r84cjtmmgs6o4fumr525cm7a8e